Seminar Recording · Safety & Neurobiology
5-MeO-DMT, Psychedelics & Psychosis
With Haley Maria Dourron
An examination of the atypical neurobiological and phenomenological risks associated with 5-MeO-DMT, including reactivations, seizure-like activity, and why this compound cannot be understood or communicated like other psychedelics.
Free Seminar Library
Enter your email to watch
Get instant access to every FIVE seminar recording, plus new research, seminar dates and recordings in your inbox.
What you'll learn
- Why 5-MeO-DMT is pharmacologically and phenomenologically distinct from classical psychedelics
- What "reactivations" are, how they differ from HPPD, and why terminology matters
- Evidence linking 5-HT1A-dominant activity to seizure-like and dissociative phenomena
- How route of administration, dosing patterns, and metabolism may influence risk
Information shared by seminar speakers does not necessarily represent the views, thoughts, and opinions of The FIVE Institute.